KRISABLIS Trademark

Trademark Overview


On Wednesday, January 25, 2017, a trademark application was filed for KRISABLIS with the United States Patent and Trademark Office. The USPTO has given the KRISABLIS trademark a serial number of 87313377. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 8, 2024. This trademark is owned by GlaxoSmithKline LLC. The KRISABLIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, rheumatoid arthritis, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; vaccines
krisablis

General Information


Serial Number87313377
Word MarkKRISABLIS
Filing DateWednesday, January 25, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 8, 2024
Registration Number5270651
Registration DateTuesday, August 22, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 6, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, rheumatoid arthritis, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 8, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxoSmithKline LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressWilmington 19808
GB

Party NameGlaxoSmithKline LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19808

Party NameGlaxoSmithKline LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19808

Trademark Events


Event DateEvent Description
Friday, March 8, 2024CANCELLED SEC. 8 (6-YR)
Friday, September 23, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 23, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 23, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 23, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 23, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, August 22, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, December 14, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, December 14, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 22, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, June 6, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 6, 2017PUBLISHED FOR OPPOSITION
Wednesday, May 17, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 28, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 20, 2017ASSIGNED TO EXAMINER
Monday, January 30, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 28, 2017NEW APPLICATION ENTERED